GO:0005575 | cellular_component | 50.68% (112/221) | 1.34 | 0.0 | 0.0 |
GO:0032991 | protein-containing complex | 23.98% (53/221) | 2.37 | 0.0 | 0.0 |
GO:0006412 | translation | 8.14% (18/221) | 4.63 | 0.0 | 0.0 |
GO:0043043 | peptide biosynthetic process | 8.14% (18/221) | 4.51 | 0.0 | 0.0 |
GO:1990904 | ribonucleoprotein complex | 10.41% (23/221) | 3.6 | 0.0 | 0.0 |
GO:0006518 | peptide metabolic process | 8.14% (18/221) | 4.25 | 0.0 | 0.0 |
GO:0003723 | RNA binding | 14.48% (32/221) | 2.72 | 0.0 | 0.0 |
GO:0043604 | amide biosynthetic process | 8.14% (18/221) | 4.12 | 0.0 | 0.0 |
GO:0110165 | cellular anatomical entity | 41.63% (92/221) | 1.24 | 0.0 | 0.0 |
GO:0044391 | ribosomal subunit | 6.33% (14/221) | 4.86 | 0.0 | 0.0 |
GO:0003735 | structural constituent of ribosome | 6.79% (15/221) | 4.55 | 0.0 | 0.0 |
GO:0043603 | amide metabolic process | 8.6% (19/221) | 3.77 | 0.0 | 0.0 |
GO:0005840 | ribosome | 6.33% (14/221) | 4.68 | 0.0 | 0.0 |
GO:0005198 | structural molecule activity | 7.69% (17/221) | 4.01 | 0.0 | 0.0 |
GO:0009987 | cellular process | 41.18% (91/221) | 1.16 | 0.0 | 0.0 |
GO:0043228 | non-membrane-bounded organelle | 10.41% (23/221) | 3.06 | 0.0 | 0.0 |
GO:0043232 | intracellular non-membrane-bounded organelle | 10.41% (23/221) | 3.06 | 0.0 | 0.0 |
GO:0043226 | organelle | 24.89% (55/221) | 1.61 | 0.0 | 0.0 |
GO:0043229 | intracellular organelle | 24.89% (55/221) | 1.61 | 0.0 | 0.0 |
GO:1901566 | organonitrogen compound biosynthetic process | 9.95% (22/221) | 3.0 | 0.0 | 0.0 |
GO:0003676 | nucleic acid binding | 21.72% (48/221) | 1.72 | 0.0 | 0.0 |
GO:0008150 | biological_process | 50.68% (112/221) | 0.87 | 0.0 | 0.0 |
GO:0006807 | nitrogen compound metabolic process | 28.96% (64/221) | 1.26 | 0.0 | 0.0 |
GO:0044271 | cellular nitrogen compound biosynthetic process | 9.5% (21/221) | 2.64 | 0.0 | 0.0 |
GO:0009059 | macromolecule biosynthetic process | 8.6% (19/221) | 2.77 | 0.0 | 0.0 |
GO:0008152 | metabolic process | 33.48% (74/221) | 1.06 | 0.0 | 0.0 |
GO:1901564 | organonitrogen compound metabolic process | 22.17% (49/221) | 1.42 | 0.0 | 0.0 |
GO:0034641 | cellular nitrogen compound metabolic process | 17.19% (38/221) | 1.69 | 0.0 | 0.0 |
GO:0003674 | molecular_function | 56.11% (124/221) | 0.67 | 0.0 | 0.0 |
GO:0015934 | large ribosomal subunit | 3.62% (8/221) | 4.78 | 0.0 | 0.0 |
GO:0071704 | organic substance metabolic process | 31.67% (70/221) | 1.05 | 0.0 | 0.0 |
GO:0044237 | cellular metabolic process | 26.7% (59/221) | 1.19 | 0.0 | 0.0 |
GO:0097159 | organic cyclic compound binding | 30.32% (67/221) | 1.08 | 0.0 | 0.0 |
GO:0044238 | primary metabolic process | 30.32% (67/221) | 1.07 | 0.0 | 0.0 |
GO:0043170 | macromolecule metabolic process | 25.34% (56/221) | 1.22 | 0.0 | 0.0 |
GO:0019538 | protein metabolic process | 18.1% (40/221) | 1.48 | 0.0 | 0.0 |
GO:0005488 | binding | 39.82% (88/221) | 0.82 | 0.0 | 0.0 |
GO:0044249 | cellular biosynthetic process | 11.31% (25/221) | 1.91 | 0.0 | 0.0 |
GO:0015935 | small ribosomal subunit | 2.71% (6/221) | 4.96 | 0.0 | 1e-06 |
GO:1901576 | organic substance biosynthetic process | 11.31% (25/221) | 1.79 | 0.0 | 2e-06 |
GO:0006396 | RNA processing | 6.79% (15/221) | 2.49 | 0.0 | 3e-06 |
GO:0022625 | cytosolic large ribosomal subunit | 2.71% (6/221) | 4.65 | 0.0 | 4e-06 |
GO:0071840 | cellular component organization or biogenesis | 10.41% (23/221) | 1.82 | 0.0 | 5e-06 |
GO:0009058 | biosynthetic process | 11.31% (25/221) | 1.71 | 0.0 | 6e-06 |
GO:0061024 | membrane organization | 3.62% (8/221) | 3.66 | 0.0 | 7e-06 |
GO:0016043 | cellular component organization | 9.5% (21/221) | 1.84 | 1e-06 | 1.2e-05 |
GO:0005730 | nucleolus | 3.62% (8/221) | 3.38 | 1e-06 | 2.9e-05 |
GO:0008114 | phosphogluconate 2-dehydrogenase activity | 0.9% (2/221) | 9.82 | 2e-06 | 4.1e-05 |
GO:0006900 | vesicle budding from membrane | 1.81% (4/221) | 5.19 | 5e-06 | 0.000105 |
GO:0043231 | intracellular membrane-bounded organelle | 15.84% (35/221) | 1.18 | 6e-06 | 0.000108 |
GO:0043227 | membrane-bounded organelle | 15.84% (35/221) | 1.16 | 7e-06 | 0.000125 |
GO:0005737 | cytoplasm | 9.5% (21/221) | 1.56 | 1.2e-05 | 0.000223 |
GO:0016050 | vesicle organization | 2.26% (5/221) | 4.07 | 1.5e-05 | 0.00027 |
GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity | 0.9% (2/221) | 8.02 | 2.8e-05 | 0.000508 |
GO:0005634 | nucleus | 9.95% (22/221) | 1.43 | 2.9e-05 | 0.000515 |
GO:0006364 | rRNA processing | 3.17% (7/221) | 3.02 | 3.1e-05 | 0.000529 |
GO:0098796 | membrane protein complex | 4.07% (9/221) | 2.54 | 3.1e-05 | 0.000536 |
GO:0016070 | RNA metabolic process | 7.69% (17/221) | 1.66 | 3.4e-05 | 0.000578 |
GO:0003729 | mRNA binding | 3.62% (8/221) | 2.68 | 4.3e-05 | 0.000712 |
GO:0051641 | cellular localization | 5.43% (12/221) | 2.03 | 4.8e-05 | 0.000773 |
GO:0016072 | rRNA metabolic process | 3.17% (7/221) | 2.91 | 5.1e-05 | 0.000808 |
GO:0019520 | aldonic acid metabolic process | 0.9% (2/221) | 7.45 | 6.2e-05 | 0.000933 |
GO:0019521 | D-gluconate metabolic process | 0.9% (2/221) | 7.45 | 6.2e-05 | 0.000933 |
GO:0046176 | aldonic acid catabolic process | 0.9% (2/221) | 7.45 | 6.2e-05 | 0.000933 |
GO:0046177 | D-gluconate catabolic process | 0.9% (2/221) | 7.45 | 6.2e-05 | 0.000933 |
GO:0006996 | organelle organization | 5.43% (12/221) | 1.94 | 8.7e-05 | 0.001284 |
GO:0022607 | cellular component assembly | 4.07% (9/221) | 2.34 | 9e-05 | 0.001305 |
GO:0035658 | Mon1-Ccz1 complex | 0.9% (2/221) | 7.05 | 0.000109 | 0.001568 |
GO:0045184 | establishment of protein localization | 4.07% (9/221) | 2.28 | 0.00012 | 0.001697 |
GO:1901360 | organic cyclic compound metabolic process | 11.76% (26/221) | 1.15 | 0.000132 | 0.001819 |
GO:0016272 | prefoldin complex | 0.9% (2/221) | 6.92 | 0.000132 | 0.001837 |
GO:0140513 | nuclear protein-containing complex | 5.43% (12/221) | 1.86 | 0.000143 | 0.001938 |
GO:0006397 | mRNA processing | 2.71% (6/221) | 2.94 | 0.000156 | 0.00209 |
GO:0072594 | establishment of protein localization to organelle | 2.71% (6/221) | 2.92 | 0.000163 | 0.002151 |
GO:0003724 | RNA helicase activity | 1.81% (4/221) | 3.9 | 0.000168 | 0.002152 |
GO:0008186 | ATP-dependent activity, acting on RNA | 1.81% (4/221) | 3.9 | 0.000168 | 0.002152 |
GO:0072655 | establishment of protein localization to mitochondrion | 1.36% (3/221) | 4.77 | 0.000198 | 0.002472 |
GO:0070585 | protein localization to mitochondrion | 1.36% (3/221) | 4.77 | 0.000198 | 0.002472 |
GO:0034470 | ncRNA processing | 3.62% (8/221) | 2.33 | 0.000229 | 0.002795 |
GO:0065003 | protein-containing complex assembly | 3.17% (7/221) | 2.55 | 0.000229 | 0.002821 |
GO:0032040 | small-subunit processome | 1.81% (4/221) | 3.76 | 0.000241 | 0.002865 |
GO:0030684 | preribosome | 2.26% (5/221) | 3.2 | 0.00024 | 0.002885 |
GO:0033365 | protein localization to organelle | 2.71% (6/221) | 2.81 | 0.000249 | 0.002924 |
GO:0008104 | protein localization | 4.07% (9/221) | 2.13 | 0.000267 | 0.003094 |
GO:0070727 | cellular macromolecule localization | 4.07% (9/221) | 2.12 | 0.000271 | 0.003109 |
GO:0033036 | macromolecule localization | 4.07% (9/221) | 2.12 | 0.000275 | 0.003117 |
GO:0016071 | mRNA metabolic process | 3.17% (7/221) | 2.46 | 0.000337 | 0.003697 |
GO:0006139 | nucleobase-containing compound metabolic process | 10.41% (23/221) | 1.15 | 0.000337 | 0.003738 |
GO:1902494 | catalytic complex | 5.43% (12/221) | 1.73 | 0.000337 | 0.003776 |
GO:0046483 | heterocycle metabolic process | 10.86% (24/221) | 1.11 | 0.000365 | 0.003951 |
GO:0009051 | pentose-phosphate shunt, oxidative branch | 0.9% (2/221) | 6.11 | 0.000407 | 0.004362 |
GO:0022627 | cytosolic small ribosomal subunit | 1.36% (3/221) | 4.39 | 0.000433 | 0.004593 |
GO:0034660 | ncRNA metabolic process | 4.07% (9/221) | 2.02 | 0.000453 | 0.004752 |
GO:0006725 | cellular aromatic compound metabolic process | 10.86% (24/221) | 1.08 | 0.000505 | 0.005235 |
GO:0000154 | rRNA modification | 1.36% (3/221) | 4.25 | 0.000571 | 0.005863 |
GO:0000815 | ESCRT III complex | 0.9% (2/221) | 5.79 | 0.000625 | 0.00635 |
GO:0032045 | guanyl-nucleotide exchange factor complex | 0.9% (2/221) | 5.77 | 0.000651 | 0.006541 |
GO:0042274 | ribosomal small subunit biogenesis | 0.9% (2/221) | 5.71 | 0.000703 | 0.006999 |
GO:0018193 | peptidyl-amino acid modification | 2.71% (6/221) | 2.51 | 0.000726 | 0.007153 |
GO:0006098 | pentose-phosphate shunt | 0.9% (2/221) | 5.65 | 0.000758 | 0.007392 |
GO:0019888 | protein phosphatase regulator activity | 1.36% (3/221) | 4.06 | 0.000838 | 0.00809 |
GO:0015031 | protein transport | 3.17% (7/221) | 2.23 | 0.000851 | 0.008135 |
GO:0019208 | phosphatase regulator activity | 1.36% (3/221) | 4.03 | 0.000893 | 0.008455 |
GO:0002183 | cytoplasmic translational initiation | 0.9% (2/221) | 5.53 | 0.000904 | 0.008471 |
GO:0000398 | mRNA splicing, via spliceosome | 1.81% (4/221) | 3.2 | 0.00104 | 0.009656 |
GO:0019899 | enzyme binding | 2.26% (5/221) | 2.72 | 0.001083 | 0.009959 |
GO:0005771 | multivesicular body | 0.9% (2/221) | 5.35 | 0.001145 | 0.010432 |
GO:0046907 | intracellular transport | 3.62% (8/221) | 1.96 | 0.001205 | 0.010874 |
GO:0000377 | RNA splicing, via transesterification reactions with bulged adenosine as nucleophile | 1.81% (4/221) | 3.12 | 0.001268 | 0.01134 |
GO:0071806 | protein transmembrane transport | 1.36% (3/221) | 3.82 | 0.001331 | 0.011799 |
GO:0051649 | establishment of localization in cell | 3.62% (8/221) | 1.91 | 0.001489 | 0.013081 |
GO:0045292 | mRNA cis splicing, via spliceosome | 0.9% (2/221) | 5.15 | 0.001509 | 0.013139 |
GO:0090304 | nucleic acid metabolic process | 8.6% (19/221) | 1.11 | 0.001558 | 0.013446 |
GO:0035639 | purine ribonucleoside triphosphate binding | 10.41% (23/221) | 0.98 | 0.001643 | 0.014053 |
GO:0051179 | localization | 8.6% (19/221) | 1.09 | 0.001692 | 0.014226 |
GO:0000375 | RNA splicing, via transesterification reactions | 1.81% (4/221) | 3.0 | 0.00169 | 0.014325 |
GO:0071261 | Ssh1 translocon complex | 0.45% (1/221) | 9.09 | 0.001837 | 0.014685 |
GO:0005838 | proteasome regulatory particle | 0.45% (1/221) | 9.09 | 0.001837 | 0.014685 |
GO:0004386 | helicase activity | 2.26% (5/221) | 2.55 | 0.001783 | 0.014728 |
GO:0051643 | endoplasmic reticulum localization | 0.9% (2/221) | 5.02 | 0.001814 | 0.01474 |
GO:0061817 | endoplasmic reticulum-plasma membrane tethering | 0.9% (2/221) | 5.02 | 0.001814 | 0.01474 |
GO:0005789 | endoplasmic reticulum membrane | 1.81% (4/221) | 2.99 | 0.001772 | 0.014768 |
GO:0008320 | protein transmembrane transporter activity | 0.9% (2/221) | 4.94 | 0.00201 | 0.01496 |
GO:0140318 | protein transporter activity | 0.9% (2/221) | 4.94 | 0.00201 | 0.01496 |
GO:0030150 | protein import into mitochondrial matrix | 0.9% (2/221) | 4.94 | 0.00201 | 0.01496 |
GO:0022884 | macromolecule transmembrane transporter activity | 0.9% (2/221) | 4.93 | 0.002032 | 0.015012 |
GO:0008353 | RNA polymerase II CTD heptapeptide repeat kinase activity | 0.9% (2/221) | 4.95 | 0.001988 | 0.015141 |
GO:0050794 | regulation of cellular process | 9.95% (22/221) | 0.98 | 0.001974 | 0.015155 |
GO:0065007 | biological regulation | 10.86% (24/221) | 0.93 | 0.001914 | 0.015172 |
GO:0004674 | protein serine/threonine kinase activity | 4.07% (9/221) | 1.72 | 0.001934 | 0.01521 |
GO:0006740 | NADPH regeneration | 0.9% (2/221) | 4.96 | 0.001966 | 0.015211 |
GO:0006839 | mitochondrial transport | 1.36% (3/221) | 3.63 | 0.001951 | 0.015217 |
GO:0031090 | organelle membrane | 3.62% (8/221) | 1.83 | 0.002127 | 0.015593 |
GO:0000469 | obsolete cleavage involved in rRNA processing | 0.45% (1/221) | 8.82 | 0.002205 | 0.016041 |
GO:0005852 | eukaryotic translation initiation factor 3 complex | 0.9% (2/221) | 4.8 | 0.00243 | 0.017552 |
GO:0090150 | establishment of protein localization to membrane | 1.36% (3/221) | 3.51 | 0.002484 | 0.01768 |
GO:0005681 | spliceosomal complex | 1.81% (4/221) | 2.85 | 0.002471 | 0.017715 |
GO:1904161 | DNA synthesis involved in UV-damage excision repair | 0.45% (1/221) | 8.6 | 0.002572 | 0.018168 |
GO:0009313 | oligosaccharide catabolic process | 0.9% (2/221) | 4.67 | 0.002915 | 0.020446 |
GO:0008380 | RNA splicing | 1.81% (4/221) | 2.77 | 0.002998 | 0.020734 |
GO:0032968 | positive regulation of transcription elongation by RNA polymerase II | 0.9% (2/221) | 4.65 | 0.002995 | 0.02086 |
GO:0034243 | regulation of transcription elongation by RNA polymerase II | 0.9% (2/221) | 4.6 | 0.003214 | 0.022071 |
GO:0008173 | RNA methyltransferase activity | 1.36% (3/221) | 3.36 | 0.003282 | 0.022374 |
GO:0034513 | box H/ACA snoRNA binding | 0.45% (1/221) | 8.24 | 0.003305 | 0.022378 |
GO:0050789 | regulation of biological process | 9.95% (22/221) | 0.91 | 0.003565 | 0.023645 |
GO:0006334 | nucleosome assembly | 0.9% (2/221) | 4.53 | 0.003528 | 0.023722 |
GO:0036452 | ESCRT complex | 0.9% (2/221) | 4.52 | 0.003557 | 0.023754 |
GO:0071705 | nitrogen compound transport | 3.62% (8/221) | 1.69 | 0.003856 | 0.025401 |
GO:0140535 | intracellular protein-containing complex | 3.17% (7/221) | 1.82 | 0.004076 | 0.026493 |
GO:0008649 | rRNA methyltransferase activity | 0.9% (2/221) | 4.42 | 0.00407 | 0.026633 |
GO:0070816 | obsolete phosphorylation of RNA polymerase II C-terminal domain | 0.9% (2/221) | 4.39 | 0.004227 | 0.026762 |
GO:0043933 | protein-containing complex organization | 3.17% (7/221) | 1.81 | 0.00422 | 0.026892 |
GO:0140534 | endoplasmic reticulum protein-containing complex | 1.36% (3/221) | 3.23 | 0.004206 | 0.026977 |
GO:0071011 | precatalytic spliceosome | 0.9% (2/221) | 4.38 | 0.004291 | 0.026989 |
GO:0003746 | translation elongation factor activity | 0.9% (2/221) | 4.4 | 0.004195 | 0.02709 |
GO:0031207 | Sec62/Sec63 complex | 0.45% (1/221) | 7.82 | 0.004404 | 0.027351 |
GO:0080183 | response to photooxidative stress | 0.45% (1/221) | 7.82 | 0.004404 | 0.027351 |
GO:0000159 | protein phosphatase type 2A complex | 0.9% (2/221) | 4.34 | 0.004549 | 0.027723 |
GO:0043414 | macromolecule methylation | 1.81% (4/221) | 2.6 | 0.00458 | 0.027734 |
GO:0051082 | unfolded protein binding | 1.36% (3/221) | 3.18 | 0.004621 | 0.02781 |
GO:0000785 | chromatin | 1.36% (3/221) | 3.19 | 0.004536 | 0.027814 |
GO:0035339 | SPOTS complex | 0.45% (1/221) | 7.71 | 0.00477 | 0.027851 |
GO:0090156 | intracellular sphingolipid homeostasis | 0.45% (1/221) | 7.71 | 0.00477 | 0.027851 |
GO:0140098 | catalytic activity, acting on RNA | 3.62% (8/221) | 1.64 | 0.004723 | 0.027909 |
GO:0071702 | organic substance transport | 4.07% (9/221) | 1.53 | 0.004525 | 0.027924 |
GO:0005829 | cytosol | 4.07% (9/221) | 1.52 | 0.00468 | 0.027994 |
GO:0006739 | NADP metabolic process | 0.9% (2/221) | 4.31 | 0.004715 | 0.02803 |
GO:1990234 | transferase complex | 3.17% (7/221) | 1.77 | 0.004919 | 0.028379 |
GO:0007165 | signal transduction | 4.07% (9/221) | 1.51 | 0.004907 | 0.028481 |
GO:0001510 | RNA methylation | 1.36% (3/221) | 3.14 | 0.005045 | 0.028934 |
GO:0018205 | peptidyl-lysine modification | 1.36% (3/221) | 3.14 | 0.005075 | 0.028936 |
GO:0033185 | dolichol-phosphate-mannose synthase complex | 0.45% (1/221) | 7.6 | 0.005136 | 0.029117 |
GO:0032511 | late endosome to vacuole transport via multivesicular body sorting pathway | 0.9% (2/221) | 4.23 | 0.005227 | 0.029459 |
GO:0140994 | RNA polymerase II CTD heptapeptide repeat modifying activity | 0.9% (2/221) | 4.22 | 0.005297 | 0.029683 |
GO:0051156 | glucose 6-phosphate metabolic process | 0.9% (2/221) | 4.21 | 0.005368 | 0.029907 |
GO:0072657 | protein localization to membrane | 1.36% (3/221) | 3.1 | 0.00546 | 0.030247 |
GO:0140640 | catalytic activity, acting on a nucleic acid | 4.98% (11/221) | 1.3 | 0.005668 | 0.030704 |
GO:0008135 | translation factor activity, RNA binding | 1.36% (3/221) | 3.08 | 0.005667 | 0.030868 |
GO:0090079 | translation regulator activity, nucleic acid binding | 1.36% (3/221) | 3.08 | 0.005667 | 0.030868 |
GO:0031167 | rRNA methylation | 0.9% (2/221) | 4.16 | 0.005764 | 0.031049 |
GO:0005770 | late endosome | 0.9% (2/221) | 4.18 | 0.005655 | 0.031149 |
GO:0034728 | nucleosome organization | 0.9% (2/221) | 4.15 | 0.005837 | 0.031272 |
GO:0018105 | peptidyl-serine phosphorylation | 1.36% (3/221) | 3.05 | 0.005945 | 0.031501 |
GO:0018209 | peptidyl-serine modification | 1.36% (3/221) | 3.05 | 0.005945 | 0.031501 |
GO:0051234 | establishment of localization | 7.69% (17/221) | 0.99 | 0.006099 | 0.032144 |
GO:0017076 | purine nucleotide binding | 11.76% (26/221) | 0.76 | 0.00616 | 0.032291 |
GO:0044743 | protein transmembrane import into intracellular organelle | 0.9% (2/221) | 4.1 | 0.006249 | 0.032407 |
GO:0008650 | rRNA (uridine-2'-O-)-methyltransferase activity | 0.45% (1/221) | 7.32 | 0.006234 | 0.032502 |
GO:0090158 | endoplasmic reticulum membrane organization | 0.9% (2/221) | 4.06 | 0.006556 | 0.033821 |
GO:0003938 | IMP dehydrogenase activity | 0.45% (1/221) | 7.24 | 0.006599 | 0.033864 |
GO:0003682 | chromatin binding | 1.81% (4/221) | 2.43 | 0.006887 | 0.035154 |
GO:0004088 | carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity | 0.45% (1/221) | 7.16 | 0.006965 | 0.035183 |
GO:0005524 | ATP binding | 9.05% (20/221) | 0.88 | 0.006941 | 0.035245 |
GO:0006605 | protein targeting | 1.36% (3/221) | 2.96 | 0.007118 | 0.035772 |
GO:0006886 | intracellular protein transport | 2.26% (5/221) | 2.08 | 0.007168 | 0.035839 |
GO:0032786 | positive regulation of DNA-templated transcription, elongation | 0.9% (2/221) | 3.98 | 0.007354 | 0.036029 |
GO:0035556 | intracellular signal transduction | 2.26% (5/221) | 2.07 | 0.007249 | 0.036062 |
GO:0005848 | mRNA cleavage stimulating factor complex | 0.45% (1/221) | 7.09 | 0.00733 | 0.036093 |
GO:0031120 | snRNA pseudouridine synthesis | 0.45% (1/221) | 7.09 | 0.00733 | 0.036093 |
GO:0098798 | mitochondrial protein-containing complex | 1.36% (3/221) | 2.91 | 0.007859 | 0.037379 |
GO:0071985 | multivesicular body sorting pathway | 0.9% (2/221) | 3.93 | 0.00781 | 0.037511 |
GO:0032509 | endosome transport via multivesicular body sorting pathway | 0.9% (2/221) | 3.93 | 0.00781 | 0.037511 |
GO:0000470 | maturation of LSU-rRNA | 0.9% (2/221) | 3.93 | 0.007852 | 0.037528 |
GO:0045182 | translation regulator activity | 1.36% (3/221) | 2.9 | 0.007957 | 0.037663 |
GO:1903293 | phosphatase complex | 0.9% (2/221) | 3.94 | 0.007768 | 0.037681 |
GO:0008287 | protein serine/threonine phosphatase complex | 0.9% (2/221) | 3.94 | 0.007768 | 0.037681 |
GO:0003839 | gamma-glutamylcyclotransferase activity | 0.45% (1/221) | 6.95 | 0.00806 | 0.037963 |
GO:0061928 | glutathione specific gamma-glutamylcyclotransferase activity | 0.45% (1/221) | 6.89 | 0.008425 | 0.039114 |
GO:0072588 | box H/ACA RNP complex | 0.45% (1/221) | 6.89 | 0.008425 | 0.039114 |
GO:0031429 | box H/ACA snoRNP complex | 0.45% (1/221) | 6.89 | 0.008425 | 0.039114 |
GO:0004349 | glutamate 5-kinase activity | 0.45% (1/221) | 6.82 | 0.008789 | 0.040422 |
GO:0006414 | translational elongation | 0.9% (2/221) | 3.85 | 0.00876 | 0.040479 |
GO:1990542 | mitochondrial transmembrane transport | 0.9% (2/221) | 3.82 | 0.009073 | 0.04153 |
GO:0005854 | nascent polypeptide-associated complex | 0.45% (1/221) | 6.77 | 0.009154 | 0.041705 |
GO:0033617 | mitochondrial cytochrome c oxidase assembly | 0.45% (1/221) | 6.71 | 0.009518 | 0.042766 |
GO:0008535 | respiratory chain complex IV assembly | 0.45% (1/221) | 6.71 | 0.009518 | 0.042766 |
GO:0051336 | regulation of hydrolase activity | 0.9% (2/221) | 3.79 | 0.009482 | 0.042999 |
GO:0008168 | methyltransferase activity | 2.26% (5/221) | 1.95 | 0.010068 | 0.045028 |
GO:0048194 | Golgi vesicle budding | 0.45% (1/221) | 6.6 | 0.010247 | 0.045618 |
GO:0016570 | histone modification | 1.36% (3/221) | 2.76 | 0.010303 | 0.045662 |
GO:0006091 | generation of precursor metabolites and energy | 1.81% (4/221) | 2.24 | 0.010724 | 0.046887 |
GO:0032784 | regulation of DNA-templated transcription elongation | 0.9% (2/221) | 3.69 | 0.010806 | 0.047037 |
GO:0000166 | nucleotide binding | 11.76% (26/221) | 0.69 | 0.01072 | 0.047083 |
GO:1901265 | nucleoside phosphate binding | 11.76% (26/221) | 0.69 | 0.01072 | 0.047083 |
GO:0090114 | COPII-coated vesicle budding | 0.45% (1/221) | 6.5 | 0.010974 | 0.047137 |
GO:0005742 | mitochondrial outer membrane translocase complex | 0.45% (1/221) | 6.5 | 0.010974 | 0.047137 |
GO:0098799 | outer mitochondrial membrane protein complex | 0.45% (1/221) | 6.5 | 0.010974 | 0.047137 |
GO:0030515 | snoRNA binding | 0.9% (2/221) | 3.66 | 0.011248 | 0.048102 |
GO:0030686 | 90S preribosome | 0.9% (2/221) | 3.65 | 0.011298 | 0.048103 |
GO:0016628 | oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor | 0.9% (2/221) | 3.64 | 0.011498 | 0.048112 |
GO:0140056 | organelle localization by membrane tethering | 0.9% (2/221) | 3.64 | 0.011498 | 0.048112 |
GO:0022406 | membrane docking | 0.9% (2/221) | 3.64 | 0.011498 | 0.048112 |
GO:0002178 | palmitoyltransferase complex | 0.45% (1/221) | 6.41 | 0.011702 | 0.048345 |
GO:0031211 | endoplasmic reticulum palmitoyltransferase complex | 0.45% (1/221) | 6.41 | 0.011702 | 0.048345 |
GO:0017059 | serine C-palmitoyltransferase complex | 0.45% (1/221) | 6.41 | 0.011702 | 0.048345 |
GO:0045324 | late endosome to vacuole transport | 0.9% (2/221) | 3.62 | 0.01185 | 0.048546 |
GO:0016741 | transferase activity, transferring one-carbon groups | 2.26% (5/221) | 1.9 | 0.011821 | 0.04863 |
GO:0032259 | methylation | 1.81% (4/221) | 2.21 | 0.011493 | 0.04872 |
GO:0009931 | calcium-dependent protein serine/threonine kinase activity | 0.9% (2/221) | 3.6 | 0.012054 | 0.048969 |
GO:0010857 | calcium-dependent protein kinase activity | 0.9% (2/221) | 3.6 | 0.012054 | 0.048969 |
GO:0004488 | methylenetetrahydrofolate dehydrogenase (NADP+) activity | 0.45% (1/221) | 6.32 | 0.012429 | 0.049461 |
GO:0004486 | methylenetetrahydrofolate dehydrogenase [NAD(P)+] activity | 0.45% (1/221) | 6.32 | 0.012429 | 0.049461 |
GO:0004477 | methenyltetrahydrofolate cyclohydrolase activity | 0.45% (1/221) | 6.32 | 0.012429 | 0.049461 |
GO:0004683 | calmodulin-dependent protein kinase activity | 0.9% (2/221) | 3.59 | 0.012259 | 0.049596 |
GO:0044389 | ubiquitin-like protein ligase binding | 0.9% (2/221) | 3.58 | 0.012518 | 0.049612 |